PortfoliosLab logoPortfoliosLab logo
SBIO vs. ENFR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SBIO vs. ENFR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALPS Medical Breakthroughs ETF (SBIO) and Alerian Energy Infrastructure ETF (ENFR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SBIO achieves a 19.82% return, which is significantly lower than ENFR's 25.22% return. Both investments have delivered pretty close results over the past 10 years, with SBIO having a 12.17% annualized return and ENFR not far ahead at 12.36%.


SBIO

1D
0.87%
1M
14.60%
YTD
19.82%
6M
16.01%
1Y
101.12%
3Y*
26.56%
5Y*
4.91%
10Y*
12.17%

ENFR

1D
1.66%
1M
-2.13%
YTD
25.22%
6M
25.45%
1Y
28.02%
3Y*
28.35%
5Y*
20.12%
10Y*
12.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SBIO vs. ENFR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SBIO
ALPS Medical Breakthroughs ETF
19.82%55.07%3.81%8.68%-28.08%-17.55%21.17%50.30%-11.81%45.67%
ENFR
Alerian Energy Infrastructure ETF
25.22%5.88%42.17%15.63%17.48%39.97%-24.14%21.60%-18.67%-0.19%

Correlation

The correlation between SBIO and ENFR is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since Dec 31, 2014

0.29

The correlation between SBIO and ENFR shifts across timeframes, from -0.07 (1 year) to 0.30 (10 years), reflecting how their relationship changes across market environments.

SBIO vs. ENFR - Sectors Allocation Comparison


Sectors
SBIO
ENFR

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

98.5%

Industrials

-

3.4%

Real Estate

-

-

Technology

-

-

Utilities

-

1.4%

Financial Services

-0.0%
0.1%

Healthcare

SBIO
100.0%
ENFR

-

Basic Materials

SBIO

-

ENFR

-

Communication Services

SBIO

-

ENFR

-

Consumer Cyclical

SBIO

-

ENFR

-

Consumer Defensive

SBIO

-

ENFR

-

Energy

SBIO

-

ENFR
98.5%

Industrials

SBIO

-

ENFR
3.4%

Real Estate

SBIO

-

ENFR

-

Technology

SBIO

-

ENFR

-

Utilities

SBIO

-

ENFR
1.4%

Financial Services

SBIO
-0.0%
ENFR
0.1%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SBIO vs. ENFR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBIO
SBIO Risk / Return Rank: 9494
Overall Rank
SBIO Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 9494
Sortino Ratio Rank
SBIO Omega Ratio Rank: 9090
Omega Ratio Rank
SBIO Calmar Ratio Rank: 9696
Calmar Ratio Rank
SBIO Martin Ratio Rank: 9494
Martin Ratio Rank

ENFR
ENFR Risk / Return Rank: 6464
Overall Rank
ENFR Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
ENFR Sortino Ratio Rank: 6565
Sortino Ratio Rank
ENFR Omega Ratio Rank: 6161
Omega Ratio Rank
ENFR Calmar Ratio Rank: 7474
Calmar Ratio Rank
ENFR Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SBIO vs. ENFR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Alerian Energy Infrastructure ETF (ENFR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SBIOENFRDifference
Sharpe ratioReturn per unit of total volatility

+1.46

Sortino ratioReturn per unit of downside risk

+1.60

Omega ratioGain probability vs. loss probability

1.50

1.32

+0.18

Calmar ratioReturn relative to maximum drawdown

8.03

3.26

+4.78

Martin ratioReturn relative to average drawdown

22.41

8.24

+14.17

SBIO vs. ENFR - Sharpe Ratio Comparison

The current SBIO Sharpe Ratio is 3.34, which is higher than the ENFR Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of SBIO and ENFR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SBIO vs. ENFR - Drawdown Comparison

The maximum SBIO drawdown since its inception was -63.06%, smaller than the maximum ENFR drawdown of -68.28%. Use the drawdown chart below to compare losses from any high point for SBIO and ENFR.


Loading charts...

Drawdown Indicators


SBIOENFRDifference

Max Drawdown

Largest peak-to-trough decline

-63.06%

-68.28%

+5.22%

Max Drawdown (1Y)

Largest decline over 1 year

-12.66%

-8.64%

-4.02%

Max Drawdown (3Y)

Largest decline over 3 years

-42.44%

-15.58%

-26.86%

Max Drawdown (5Y)

Largest decline over 5 years

-53.10%

-20.29%

-32.81%

Max Drawdown (10Y)

Largest decline over 10 years

-63.06%

-62.64%

-0.42%

Current Drawdown

Current decline from peak

0.00%

-4.48%

+4.48%

Average Drawdown

Average peak-to-trough decline

-28.35%

-15.93%

-12.42%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

3.41%

+1.12%

Volatility

SBIO vs. ENFR - Volatility Comparison

ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 11.21% compared to Alerian Energy Infrastructure ETF (ENFR) at 5.61%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than ENFR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SBIOENFRDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.21%

5.61%

+5.60%

Volatility (6M)

Calculated over the trailing 6-month period

23.69%

11.78%

+11.91%

Volatility (1Y)

Calculated over the trailing 1-year period

30.43%

14.98%

+15.45%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.76%

19.27%

+14.49%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.19%

24.68%

+8.51%

SBIO vs. ENFR - Expense Ratio Comparison

SBIO has a 0.50% expense ratio, which is higher than ENFR's 0.35% expense ratio.


Dividends

SBIO vs. ENFR - Dividend Comparison

SBIO has not paid dividends to shareholders, while ENFR's dividend yield for the trailing twelve months is around 4.01%.


PositionTTM20252024202320222021202020192018201720162015
ENFR
Alerian Energy Infrastructure ETF
4.01%4.77%4.41%5.48%5.23%7.86%7.57%5.81%3.98%2.98%3.31%3.34%
SBIO
ALPS Medical Breakthroughs ETF
0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%

Frequently Asked Questions


SBIO and ENFR have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SBIO has higher volatility (11.21%) compared to ENFR (5.61%). In terms of maximum drawdown, SBIO dropped -63.06% vs ENFR's -68.28%.

On 10-year performance, ENFR leads with 12.36% vs 12.17% for SBIO. On fees, ENFR is cheaper at 0.35% per year. On volatility, ENFR has been the lower-risk option at 5.61%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, ENFR has performed better with a 12.36% return vs 12.17%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

ENFR is cheaper with a 0.35% expense ratio, compared with 0.50% for SBIO.

ENFR has the higher dividend yield at 4.01%, compared with 0.00% for SBIO.

SBIO is categorized as Health & Biotech Equities, while ENFR is Energy Equities. SBIO tracks S-Network Medical Breakthroughs Index, while ENFR tracks Alerian Midstream Energy Select Index. Their fees differ too: 0.50% for SBIO and 0.35% for ENFR.

SBIO currently has the higher Sharpe Ratio (3.34 vs 1.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SBIO and ENFR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer